Walleye Capital LLC Roivant Sciences Ltd. Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.17 - $12.5 $326,457 - $401,250
-32,100 Reduced 82.52%
6,800 $78,000
Q2 2024

Aug 14, 2024
BUY
$10.36 - $11.74 $401,968 - $455,512
38,800 Added 38800.0%
38,900 $411,000
Q1 2024

May 15, 2024
SELL
$9.87 - $11.8 $73,038 - $87,320
-7,400 Reduced 98.67%
100 $1,000
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $62,850 - $86,850
7,500 New
7,500 $84,000

Others Institutions Holding ROIV

# of Institutions
310
Shares Held
507M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email